Resverlogix Resverlogix is a clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses. | ![]() Ionis Pharmaceuticals Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics. | ![]() Nemesis Bioscience Nemesis Bioscience is a biopharmaceutical company developing DNA therapeutics administered before antibiotics to inactivate resistance in bacterial pathogens. | |||
Founding Date | Founding Date 2004 | Founding Date 2001 | Founding Date 1989 | Founding Date 2014 | Founding Date 2015 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Fremont, US HQ | Locations Calgary, CA HQ San Francisco, US | Locations Babraham, GB HQ | Locations Philadelphia, US HQ | |
Employees | Employees N/A | Employees 19 | Employees 1,40231% increase | Employees N/A | Employees 12 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 12.9 m | Valuation ($) 6.3 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $943.7m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $15.9m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $50k (FY, 2025) | Gross profit $927.8m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income ($7.8m) (FY, 2025) | Net income ($381.4m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 908.1k (about 9 years ago) | Latest funding round $ 845k (almost 10 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 10m | Total funding raised N/A | Total funding raised $ 1.4m | Total funding raised $ 845k |
Resverlogix is a clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses.
View company
Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
View company
Nemesis Bioscience is a biopharmaceutical company developing DNA therapeutics administered before antibiotics to inactivate resistance in bacterial pathogens.
View company
Chimeron Bio is a company focused on RNA (ribonucleic acid) therapeutics.
View company